Logo

MWG Biotech Buys Another 454 Sequencer

Apr 15, 2008
NEW YORK (GenomeWeb News) – The German sequencing services company MWG Biotech has purchased a Genome Sequencer FLX system from 454 Life Sciences of the Roche Group, 454 said today.
 
This is MWG Biotech’s second GS FLX purchase. The Branford, Conn.-based Roche subsidiary said the system will allow MWG to improve the quality and enhance the speed of its sequencing services.
 
The GS FLX is used for de novo sequencing and re-sequencing of genomes, metagenomics, RNA analysis, and targeted sequencing of specific DNA regions, 454 said.
 
MWG Biotech bought its first GS FLX in July of last year.
 
 

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.